Non-Autoimmune Hemolytic Anemia with Clostridium Ramosum Bacteremia

由 Al-kali, Aref, Oswal, Alok, Tfayli, Arafat
出版 2008

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)

由 Al-Kali, Aref, Wierda, William, Keating, Michael, O’Brien, Susan
出版 2010

The Role of Monoclonal Antibodies in the Management of Leukemia

由 Al-Ameri, Ali, Cherry, Mohamad, Al-Kali, Aref, Ferrajoli, Alessandra
出版 2010

Competing cell clones in myeloproliferative neoplasm

由 Al-Kali, Aref, Verstovsek, Srdan, Kantarjian, Hagop, Luthra, Rajyalakshmi, Cortes, Jorge
發表在 Blood (2010)

An Erythrocytosis-Associated Mutation in the Zinc Finger of PHD2 Provides Insights into Its Binding of p23

由 Song, Daisheng, Guan, Wei, Coon, Lea M, Al-Kali, Aref, Oliveira, Jennifer L, Lee, Frank S
發表在 Hypoxia (Auckl) (2019)

A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis

由 Shen, Na, Yan, Fei, Pang, Jiuxia, Wu, Lai-Chu, Al-Kali, Aref, Litzow, Mark R., Liu, Shujun
出版 2014

Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia

由 Al-Kali, Aref, Cortes, Jorge, Faderl, Stefan, Jones, Dan, Abril, Caroline, Pierce, Sherry, Brandt, Mark, Kantarjian, Hagop, Ravandi, Farhad
出版 2011

A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome

由 Almasri, Jehad, Alkhateeb, Hassan B., Firwana, Belal, Sonbol, Mohamad Bassam, Damlaj, Moussab, Wang, Zhen, Murad, M. Hassan, Al-Kali, Aref
發表在 Syst Rev (2018)

A dynamic N(6)-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors

由 Yan, Fei, Al-Kali, Aref, Zhang, Zijie, Liu, Jun, Pang, Jiuxia, Zhao, Na, He, Chuan, Litzow, Mark R., Liu, Shujun
發表在 Cell Res (2018)

Current Event-Free Survival After Sequential Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia

由 Al-Kali, Aref, Kantarjian, Hagop, Shan, Jianqin, Bassett, Roland, Quintás-Cardama, Alfonso, Borthakur, Gautam, Jabbour, Elias, Verstovsek, Srdan, O’Brien, Susan, Cortes, Jorge
發表在 Cancer (2010)

Inactivation of receptor tyrosine kinases reverts aberrant DNA methylation in acute myeloid leukemia

由 Shen, Na, Yan, Fei, Pang, Jiuxia, Zhao, Na, Gangat, Naseema, Wu, Laichu, Bode, Ann M., Al-Kali, Aref, Litzow, Mark R., Liu, Shujun
發表在 Clin Cancer Res (2017)

Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients

由 Al-Kali, Aref, Konoplev, Sergej, Lin, Erpei, Kadia, Tapan, Faderl, Stefan, Ravandi, Farhad, Ayoubi, Mohamad, Brandt, Mark, Cortes, Jorge E., Kantarjian, Hagop, Borthakur, Gautam
出版 2012

Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis

由 Yang, Xiaojuan, Pang, Jiuxia, Shen, Na, Yan, Fei, Wu, Lai-Chu, Al-Kali, Aref, Litzow, Mark R., Peng, Yong, Lee, Robert J., Liu, Shujun
發表在 Oncotarget (2016)

Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology

由 Osman, Mazen, Akkus, Zeynettin, Jevremovic, Dragan, Nguyen, Phuong L., Roh, Dana, Al-Kali, Aref, Patnaik, Mrinal M., Nanaa, Ahmad, Rizk, Samia, Salama, Mohamed E.
發表在 J Clin Med (2021)

Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal orig...

由 Patnaik, Mrinal M., Lasho, Terra, Howard, Matthew, Finke, Christy, Ketterling, Rhett L., Al-Kali, Aref, Pardanani, Animesh, Droin, Nathalie, Gangat, Naseema, Tefferi, Ayalew, Solary, Eric
發表在 Blood Cancer J (2018)

Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS‐CoV‐2 pandemic

由 Patnaik, Mrinal M., Lasho, Terra, Padron, Eric, McCullough, Kristen, Al‐kali, Aref, Tefferi, Ayalew, Zeidan, Amer M., Gangat, Naseema, Savona, Michael, Steensma, David P., Solary, Eric
發表在 Am J Hematol (2020)

One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience

由 Tefferi, Ayalew, Lasho, Terra L., Jimma, Thitina, Finke, Christy M., Gangat, Naseema, Vaidya, Rakhee, Begna, Kebede H., Al-Kali, Aref, Ketterling, Rhett P., Hanson, Curtis A., Pardanani, Animesh
出版 2012

The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia

由 Tibes, Raoul, Al-Kali, Aref, Oliver, Gavin R, Delman, Devora H, Hansen, Nanna, Bhagavatula, Keerthi, Mohan, Jayaram, Rakhshan, Fariborz, Wood, Thomas, Foran, James M., Mesa, Ruben A., Bogenberger, James M.
發表在 J Hematol Oncol (2015)

Histone deacetylase inhibitors reduce differentiating osteoblast-mediated protection of acute myeloid leukemia cells from cytarabine

由 Sterner, Rosalie M., Kremer, Kimberly N., Al-Kali, Aref, Patnaik, Mrinal M., Gangat, Naseema, Litzow, Mark R., Kaufmann, Scott H., Westendorf, Jennifer J., van Wijnen, Andre J., Hedin, Karen E.
發表在 Oncotarget (2017)

Momelotinib therapy for myelofibrosis: a 7-year follow-up

由 Tefferi, Ayalew, Barraco, Daniela, Lasho, Terra L., Shah, Sahrish, Begna, Kebede H., Al-Kali, Aref, Hogan, William J., Litzow, Mark R., Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema, Pardanani, Animesh
發表在 Blood Cancer J (2018)